Join the Biliary Cirrhosis group to help and get support from people like you.
Biliary Cirrhosis News
Related terms: PBC, Primary Biliary Cirrhosis, Biliary Cholangitis
Seladelpar Beneficial for Patients With Primary Biliary Cholangitis
MONDAY, Feb. 26, 2024 – For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and ...
FDA Medwatch Alert: FDA Restricts Use of Ocaliva (obeticholic acid) in Primary Biliary Cholangitis Patients with Advanced Cirrhosis Due to Risk of Serious Liver Injury
ISSUE: The FDA is restricting the use of the liver disease medicine Ocaliva (obeticholic acid) in patients having primary biliary cholangitis (PBC) with advanced cirrhosis of the liver because it can ...
FDA Medwatch Alert: Ocaliva (obeticholic acid): Drug Safety Communication - Increased Risk of Serious Liver Injury
ISSUE: FDA is warning that the liver disease medicine Ocaliva (obeticholic acid) is being incorrectly dosed in some patients with moderate to severe decreases in liver function, resulting in an...
FDA Grants Accelerated Approval to Ocaliva (obeticholic acid) for Primary Biliary Cholangitis
NEW YORK, May 27, 2016 (GLOBE NEWSWIRE) – Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat...
Ask a question
To post your own question to this support group, sign in or create an account.